J. Bras. Nefrol. vol.36 número4
Texto
Documentos relacionados
Conclusions: Intravesical bacillus Calmette-Guerin is a viable therapeutic option in patients with high risk superficial bladder cancer and concomitant lymphoma or chronic
The authors review their experience with Botulinum A toxin intravesical injection in patients plagued with refractory bladder pain combined with symptoms of overactive
Conclusions: In patients with intermediate- and high-risk stage Ta and T1 urothelial bladder cancer, intravesical BCG with or without INH is superior to intravesical epirubicin
Our aim was to study the relationship between ATP and NO release in (1) early diabetic bladders, an overactive bladder model; and (2) “diuretic” bladders, an underactive
A brisk change in LUT function of women older than 75 years underlined deterioration in bladder function with a high incidence of detrusor hyperactivity with or without
However, a recent study has shown that for the high risk patients with non-muscle invasive bladder cancer (NMIBC) a single instillation of perioperative intravesical
Fifty-eight low grade papillary carcinoma patients and 36 high grade papillary carcinoma patients underwent TUR-BT (transurethral resec- tion of bladder tumor), six low
Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions. Arch Phys